Skip to content

Identifying Drug-related Problems at ED Triage (DRP-EDiT) V1

Right Place, Right Practitioner, Right Time: Development of Emergency Department Triage to Support the Identification and Management of Drug Related Problems

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05476705
Acronym
DRP-EDiT
Enrollment
110
Registered
2022-07-27
Start date
2023-04-30
Completion date
2023-09-30
Last updated
2023-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medication Administered in Error, Medication Adverse Effects, Medication Reaction

Keywords

Drug-related problems, Emergency department, Triage, Identification, Management, Pharmacists

Brief summary

Up to a third of patients who visit emergency departments (EDs) do so because they have an issue with medicines prescribed by their doctor or purchased over the counter. For example, some patients might experience side effects (e.g., sickness), whereas others may feel their prescribed medicine is not working and want an alternative. While some patients who visit EDs know they have a problem with their medication, some are not aware. Furthermore, drug-related problems (DRPs) may not be identified by ED triage systems which are used to sort patients' priority for treatment. The currently used system in the UK (Manchester Triage System) mentions drugs infrequently and does not support the identification of the most common DRPs. For this project, DRPs include medication errors, adverse drug events, and adverse drug reactions. This project aims to revise the triage system to support the discovery of patients' medication problems when they are triaged by a nurse upon arrival to the ED. After identification, problems with a patient's medication should be dealt with by the healthcare professional who is most appropriate to manage that particular issue. For example, a patient who has been prescribed a new medicine but already takes 20 medicines will likely benefit from a review by a pharmacist in the ED. This project will aim to support the management of patients who might benefit from care provided by pharmacists by providing them with this care. As well as ensuring medication problems are identified at triage, and that pharmacists are involved in helping to deal with those problems, this project will also try to understand how we can investigate how pharmacists actually make a difference to the care of ED patients. A multi-step approach (Stages A-F) is proposed to answer the question How can patient DRPs be identified, triaged and managed in the ED? In summary, the steps include: STAGE A, a systematic review and scoping survey; STAGE B, researcher visits to ED sites to shadow ED staff; STAGE C, Interviews with healthcare professionals (including those shadowed in STAGE B) to validate findings of site visits and explore topics in more depth; STAGE D, developing additional drug-related content for the Manchester Triage System; STAGE E, involving a panel of experts in a RAND appropriateness method to rate the content developed in STAGE D; STAGE F, testing the revised triage system for a future pilot study involving interviews with staff visited in STAGE B.

Interventions

None listed

Sponsors

Pharmacy Research UK
CollaboratorUNKNOWN
University of Manchester
CollaboratorOTHER
Ashford and St. Peter's Hospitals NHS Trust
CollaboratorOTHER
Anglia Ruskin University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

The following groups will be included in various stages of the project * STAGE A: ED clinicians at UK-wide NHS trusts * STAGE B: ED staff from 8 NHS sites across the UK * STAGE C: ED staff from 8 NHS sites across the UK * STAGE E: Clinicians and academics with expertise in Emergency Care and/or ED Triage * STAGE F: ED staff from 8 NHS sites across the UK

Exclusion criteria

* Those who do not consent or who are unable to consent

Design outcomes

Primary

MeasureTime frameDescription
Suitability of a revised Manchester Triage System (MTS)13 months (the revised MTS will be an output from the analysis of data collected months 1 - 13)The suitability of a revised MTS to support identification and management of drug-related problems in the Emergency Department

Contacts

Primary ContactDaniel Greenwood
daniel.greenwood@aru.ac.uk01245683082

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026